The DOI matches its Crossref record.
Using the Time of Maximum Effect Site Concentration to Combine Pharmacokinetics and Pharmacodynamics
Open accessAbstract
Background: To simulate the time course of drug effect, it is sometimes necessary to combine the pharmacodynamic parameters from an integrated pharmacodynamic-pharmacodynamic study (e.g., volumes, clearances, k(e0) [the effect site equilibration rate constant], C(50) [the steady state plasma concentration associated with 50% maximum effect], and the Hill coefficient) with pharmacokinetic parameters from a different study (e.g., a study examining a different age group or sampling over longer periods of time). Pharmacokinetic-pharmacodynamic parameters form an interlocked vector that describes the relationship between input (dose) and output (effect). Unintended consequences may result if individual elements of this vector (e.g., k(e0)) are combined with pharmacokinetic parameters from a different study. The authors propose an alternative methodology to rationally combine the results of separate pharmacokinetic and pharmacodynamic studies, based on t(peak), the time of peak effect after bolus injection. Methods: The naive approach to combining separate pharmacokinetic and pharmacodynamic studies is to simply take the k(e0) from the pharmacodynamic study and apply it naively to the pharmacokinetic study of interest. In the t(peak) approach, k(e0) is recalculated using the pharmacokinetics of interest to yield the correct time of peak effect. The authors proposed that the t(peak) method would yield better predictions of the time course of drug effect than the naive approach. They tested this hypothesis in three simulations: thiopental, remifentanil, and propofol. Results: In each set of simulations, the t(peak) method better approximated the postulated "true" time course of drug effect than the naive method. Conclusions: T(peak) is a useful pharmacodynamic parameter and can be used to link separate pharmacokinetic and pharmacodynamic studies. This addresses a common difficulty in clinical pharmacology simulation and control problems, where there is usually a wide choice of pharmacokinetic models but only one or two published pharmacokinetic-pharmacodynamic models. The results will be immediately applicable to target-controlled anesthetic infusion systems, where linkage of separate pharmacokinetic and pharmacodynamic parameters into a single model is inherent in several target-controlled infusion designs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Pharmacokinetic models for propofol—defining and illuminating the devil in the detail
Absalom, A. R., Mani, V., De Smet, T., & Struys, M. M. R. F. (2009) · British Journal of Anaesthesia · doi:10.1093/bja/aep143 · Cited by 435
Plasma pharmacokinetics of intravenous and intranasal oxytocin in nonpregnant adults
Shafer, S. L., Ririe, D. G., Miller, S., Curry, R. S., Hsu, D. T., Sullivan, G. M., & Eisenach, J. C. (2025) · British Journal of Anaesthesia · doi:10.1016/j.bja.2024.12.046 · Cited by 5
Self-citation
Metadata
- Authors
- Minto, C. F., Schnider, T. W., Gregg, K. M., Henthorn, T. K., & Shafer, S. L.
- Venue
- Anesthesiology
- Published
- 2003-08-01
- Volume
- 99
- Issue
- 2
- Pages
- 324-333
- ISSN
- 0003-3022 (ISSN-L)
- OpenAlex
- W2084406991
- Cited by
- 159
- References
- 0
- FWCI
- 7.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Using the Time of Maximum Effect Site Concentration to Combine Pharmacokinetics and Pharmacodynamics. https://app.cochat.ai/papers/10.1097/00000542-200308000-00014
- The paper
- Minto, C. F., Schnider, T. W., Gregg, K. M., Henthorn, T. K., & Shafer, S. L. (2003). Using the Time of Maximum Effect Site Concentration to Combine Pharmacokinetics and Pharmacodynamics. Anesthesiology. https://doi.org/10.1097/00000542-200308000-00014
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.